Navigation Links
Rigel's R788 Evaluated in Phase 2 Trial in Multiple Cancers
Date:6/1/2009

SOUTH SAN FRANCISCO, Calif., June 1 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that its oral Syk inhibitor, R788, is being evaluated in a Phase 2 clinical trial funded, designed and implemented by the National Cancer Institute (NCI), part of the U.S. National Institutes of Health. This open-label, single arm clinical trial will include patients with advanced colorectal, thyroid, non-small cell lung, hepatocellular, head and neck, or renal cell cancers who have failed to respond to at least one line of therapy.

Enrolled patients will receive 200 mg of R788 twice a day and will be monitored to measure a variety of clinical responses as well as drug safety. Patients will continue to receive R788 in 28-day treatment cycles until disease progression, or patient or physician withdrawal occurs. The NCI will conduct the clinical trial, Rigel will supply study drug and will receive clinical data and trial results.

"We value the NCI's expertise and support in exploring the potential of R788 in treating these solid tumors," said Elliott Grossbard, M.D., executive vice president and chief medical officer of Rigel. "These results may provide another path for further expanding R788's therapeutic potential," he added.

Rigel is presently conducting two Phase 2b clinical trials with R788, known as TASKi2 and TASKi3, in patients with rheumatoid arthritis. Results from these trials are expected in July of this year. In addition, the company has an ongoing Phase 2 clinical trial of R788 in patients with peripheral T-cell lymphoma and reported favorable results from a Phase 2 clinical trial of R788 in the treatment of patients with certain B-cell lymphomas in June 2008.

About Rigel (www.Rigel.com)

Rigel is a clin
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Advancements in Integrative Medicine Research to Be Evaluated by Scientists From Leading International Academic Health Centers
2. MDS Announces Strategy to Focus MDS Pharma Services on Early Stage Operations - Discovery Through Phase IIa
3. Poniard Pharmaceuticals Announces Positive Efficacy and Safety Data From Phase 2 Clinical Trial of Picoplatin in Men With Metastatic Prostate Cancer
4. Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer
5. Ceregene Presents Additional Clinical Data from Phase 2 Trial of CERE-120 for Parkinsons Disease
6. The National Association of Boards of Pharmacy (NABP) Moves to Next Phase of Technician Recognition and Regulation
7. MAP Pharmaceuticals Phase 3 Trial of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints
8. Bioniche Phase III Clinical Trial with Urocidin(TM) Progressing Well
9. National Medical Interpreter Certification Testing Enters Pilot Phase
10. Results of phase III study on Labopharms novel antidepressant published in Psychiatry (Edgemont) Journal
11. Trubion Pharmaceuticals, Inc. to Present Positive Data From a Phase 2b Re-treatment Study of TRU-015 at the 2009 EULAR Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... December 25, 2014 Residents at ... Community, recently showed their generous spirit by providing ... Catawba County Parenting Network- Grandparents Raising Grandchildren program. ... gathered around the largest Christmas tree on the ... purchased by residents of the Abernethy Village Association ...
(Date:12/24/2014)... (PRWEB) December 25, 2014 Over 700 ... to their local communities. That is 700 smiling little ... single gift. Additionally over $6000 in monetary donations was ... offset some of the expenses they incur through the ... drive were A Child's Haven , Shrine's Children's ...
(Date:12/24/2014)... York (PRWEB) December 24, 2014 Risperdal ... in a mass tort litigation currently underway in Pennsylvania’s ... As of December 24, 2014, court documents indicate ... on behalf of individuals who developed gynecomastia (male breast ... Data from the Court indicates that this represents an ...
(Date:12/24/2014)... 25, 2014 Today, UWDress.com, the famous women’s ... wedding gowns, and launched a site-wide wedding gown promotion. ... wedding gowns in a more unexpected way, the collection should ... popular in the global market, and they are available with ... are offered at discounted prices, up to 75% off; most ...
(Date:12/24/2014)... BambooIndustry.com a famous bamboo flooring company offering bamboo flooring ... announces its multiple layer bamboo panel board collection , ... , Bamboo panel is the product made from 100 ... board features high quality selective bamboo and eco-friendly adhesives ... panel consists of multiple layers of bamboo. , According ...
Breaking Medicine News(10 mins):Health News:Retirement Community Residents Make Impact During Holiday Season 2Health News:AlignLife Donates Over 700 Toys This Year 2Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 4Health News:Buy Cheap Long Sleeve Wedding Gowns At UWDress.com 2Health News:Bamboo Flooring Company Bambooindustry.com Introduces Its Multiple Layer Bamboo Panel Board Collection 2
... Inherent gender differences – instead of more sun exposure – ... likely than women to develop// certain kinds of skin cancer, ... ,Squamous cell carcinoma is the second most common form of ... United States each year. While occurring more often than melanoma, ...
... key challenge in the development of vaccines for bird flu, ... strain //of bird flu, the H5N1 virus, which could mutate ... nations in the world have continually exchanged information with the ... the motive of assisting scientists to be abreast with the ...
... breastfeeding a baby till it is six months old ... say//. ,The Human Immunodeficiency Virus (HIV) ... immune system begins to fail. ,Hoosen Coovadia ... and Population Studies at the University of KwaZulu-Natal, South ...
... supports the theory that bringing about senescence in aged ... ,Inducing senescence in aged cells may be sufficient to ... published online this week in European Molecular Biology Organization ... or programmed cell death – apoptosis – was the ...
... the University of Florida have initiated a project to ... secrets of regeneration from creatures with remarkable powers of ... ,Fueled by about $6 million in private donations, university ... connect scientists who work with adult human stem cells ...
... FDA launched a special Web page. This web page is ... sold by Roche// under the brand name Accutane, on the ... that is not controlled by other treatment forms. FDA warns ... severe mental health problems. ,The FDA warning page ...
Cached Medicine News:Health News:Gender Linked to Development of Skin Cancer 2Health News:Gender Linked to Development of Skin Cancer 3Health News:Breastfeeding Could Cut HIV Risk to Babies 2Health News:UF Launches Project to Bridge the Regeneration Gap 2Health News:UF Launches Project to Bridge the Regeneration Gap 3Health News:Web Page to Warn Against Online Purchase of Isotretinoin 2
(Date:12/24/2014)... , Dec. 24, 2014  Diplomat Pharmacy, Inc. (NYSE: ... pharmacy, is proud to announce Jennifer Hagerman , ... Diplomat, will take office as the president of the ... induction ceremony will take place Feb. 28, 2015, at ... held at the Renaissance Center in Detroit, ...
(Date:12/24/2014)... KENNEWICK, Wash. , Dec. 23, 2014 /PRNewswire/ ... stage development company engaged primarily in the development ... and therapeutic applications, today announced that it has ... the Food and Drug Administration ("FDA") for marketing ... to Section 513(f)(2) of the U.S. Food, Drug ...
(Date:12/24/2014)... DALLAS , Dec. 23, 2014  Lockton ... operation of Lockton Companies, announced the addition of ... Foerster will join Lockton Dunning,s Pharmacy Consulting team, ... years of relevant industry experience to the position.  ... Managed Market Sales at Diplomat Specialty Pharmacy, where ...
Breaking Medicine Technology:Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3Kim Foerster Joins Lockton Companies 2
... /PRNewswire-Asia-FirstCall/ -- China Medicine Corporation (OTC Bulletin Board: ... manufacturer, developer and distributor of Western pharmaceuticals, traditional ... the People,s Republic of China, today announced that ... to stockholder approval, the 2011 Long-Term Incentive Plan ...
... N.C., March 3, 2011 Recent ... Corporate governance changes announced Term loan repaid ... Fourth quarter 2010 financial results announced ... CSA ), healthcare,s preferred real estate partner, is a REIT ...
Cached Medicine Technology:China Medicine Corporation Adopts New Incentive Compensation Plans 2China Medicine Corporation Adopts New Incentive Compensation Plans 3Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 2Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 3Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 4Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 5Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 6Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 7Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 8Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 9Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 10Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 11Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 12Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 13Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 14Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 15Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 16
... Cross-match tubes are available ... serum tube contains a clotting ... cross-match tests where serum is ... EDTA cross-match tube is suitable ...
Inquire...
... K2 / gel tubes are for ... molecular diagnostics and for viral load ... blood remain stable at room temperature ... optimal results, it is recommended to ...
Glass Whole Blood Tube with K3EDTA...
Medicine Products: